News
Luke Greenwalt, MBA, on the Current Market Conditions for New Drug Launches | Asembia's AXS25 Summit
The vice president and lead of IQVIA's Market Access Center of Excellence says fewer drugs are hitting the $100 million mark ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
McElya, senior director, clinical pharmacy at Walgreens, notes that approximately half of the drugs approved by the FDA last year were first-in-class drugs.
Patients and providers found common ground on the importance of correct billing estimates but did not see eye to eye in terms ...
Giant Eagle also helped EmpiRx Health create a national pharmacy care network that was purpose-built for pharmacy and grocery chains.
Researchers in Taiwan find no difference in fungal disease among patients treated with two different types of GVHD ...
There is a lack of agreement on the clinical, psychological and social relevance of menopause between the transgender and ...
Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...
Experts at City of Hope, Simon Nazarian and Nasim Eftekhari, discussed the transformative potential of AI in cancer care.
Researchers of a new JAMA study said that without further participation in accountable care organizations, including the ACO REACH model, the program is unlikely to meet its goal of reducing health ...
Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.
CVS Health released a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results